8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Veristat is excited to head to Atlanta, GA for the 59th ASH Annual Meeting & Exposition taking place from December 9-12, 2017. The 2017 ASH Annual Meeting is the place to network with a global community of more than 25,000 hematology professionals who specialize in performing clinical research and treating patients with both malignant and non-malignant hematology diseases.
Visit Our Booth #3247
While this is not our first year attending ASH, it’s our first year with an exhibit booth!
Simply stop by our booth #3247 to say hello or fill out the form on the right side of this page to schedule a time to meet with Veristat at ASH to discuss your current challenges.
By visiting with Veristat at ASH, you will meet some of our senior leaders and experts who have guided our clients through the clinical trial and regulatory submission process. In the past five years, we have worked on nearly 50 blood disease/blood cancer clinical programs. And, we are currently preparing 3 regulatory submissions for leukemia, and 2 genetic blood disorders.
Learn more
Veristat can help you navigate the challenges in the clinical trial and regulatory submission process for your next hematology study or programs. Read about our hematologic malignancy experience now.